NF2 rs1060503667: What Your Genotype Means
The rs1060503667 variant is a specific genetic alteration located within the NF2 gene. It is associated with the clinical manifestations of neurofibromatosis type 2, a condition characterized by the development of tumors in the nervous system.
What each genotype means
Typical NF2 gene profile
This genotype represents the common, non-pathogenic version of the NF2 gene at this specific location. It is not associated with the development of neurofibromatosis type 2.
This is the most common genotype found in the general population.
Pathogenic NF2 variant
This genotype is classified as pathogenic and is linked to the development of neurofibromatosis type 2, an autosomal dominant condition. Individuals with this variant should consult with a medical geneticist or clinician to discuss appropriate screening and management, as penetrance is high.
This specific variant is rare in the general population.
Understanding the rs1060503667 Variant
The rs1060503667 variant is a specific change in the DNA sequence of the NF2 gene, which is located on chromosome 22. In the context of human genetics, a single nucleotide polymorphism (SNP) like this represents a variation at a single position in the genome. This particular variant is categorized as a pathogenic alteration in clinical databases. When researchers study such variants, they look at how these changes affect the structure and function of the proteins encoded by the gene. Because this variant is located within a critical tumor suppressor gene, its presence can have significant biological consequences. It is important to note that genetic variants are identified through laboratory sequencing, and their clinical significance is determined by comparing these findings against established medical research and databases that track known disease-causing mutations.
The Role of the NF2 Gene
The NF2 gene provides the essential instructions for producing a protein called merlin, also known as schwannomin. This protein acts as a tumor suppressor, meaning it helps regulate cell growth and prevents cells from dividing too rapidly or in an uncontrolled way. Merlin is primarily active in the nervous system, particularly within Schwann cells, which are the specialized cells that wrap around and insulate nerve fibers. By acting as a structural link between the cell membrane and the cytoskeleton, merlin helps maintain cell shape and regulates signaling pathways that control cell proliferation. When the NF2 gene is altered by a pathogenic variant, the production of functional merlin protein is often disrupted or reduced. Without sufficient functional merlin, the body's ability to suppress tumor growth in the nervous system is compromised, which can lead to the development of schwannomas and other related tumors.
Research and Clinical Associations
Scientific research has established a strong link between pathogenic variants in the NF2 gene and neurofibromatosis type 2 (NF2). This condition is an autosomal dominant disorder, meaning that a single copy of a pathogenic variant is sufficient to increase the risk of developing the disease. Studies have shown that individuals with these variants have a high penetrance, meaning that the clinical features of the condition are very likely to manifest over a person's lifetime. Research into the mutational spectrum of NF2 has identified various types of alterations, including those that lead to truncated or non-functional proteins. The evidence for the association between specific pathogenic NF2 variants and the clinical syndrome is considered robust in the medical community. Clinicians use this information to support diagnostic processes, though the presence of a variant is only one part of a comprehensive clinical evaluation that includes physical exams and imaging.
Population Frequency and Interpretation
The rs1060503667 variant is considered rare in the general population. Because it is associated with a specific clinical condition, it is not a common polymorphism found in the majority of healthy individuals. When interpreting genetic data, it is crucial to distinguish between common variations that contribute to normal human diversity and rare, pathogenic variants that are linked to specific health conditions. The rarity of this variant means that it is not typically encountered in standard population screening. If an individual receives a report indicating the presence of this variant, it is essential to understand that this is a clinical finding that requires professional interpretation. Genetic testing results should always be discussed with a qualified healthcare provider or a genetic counselor who can place the finding in the context of an individual's personal and family medical history.
Navigating Genetic Information
Understanding your genetic information can be a complex process. If you have received information about the rs1060503667 variant, it is important to remember that this information is for educational purposes and does not constitute a medical diagnosis. Genetic testing is a powerful tool, but it must be interpreted alongside clinical symptoms and professional medical judgment. You cannot use this information to self-diagnose or make independent medical decisions. If you are concerned about your results, the most appropriate step is to schedule an appointment with a medical geneticist or a genetic counselor. These professionals are trained to explain the implications of your specific genotype, discuss the potential for clinical screening, and help you navigate the next steps in your healthcare journey. Always rely on your clinical care team for guidance regarding your health and any necessary medical follow-up.
How common is this variant?
The rs1060503667 variant is rare across all major human populations.
Frequently asked questions
What is neurofibromatosis type 2?
Neurofibromatosis type 2 is a genetic disorder that causes the growth of noncancerous tumors in the nervous system. It is primarily characterized by the development of schwannomas on the vestibular nerves, which can affect hearing and balance.
Is rs1060503667 a common genetic variant?
No, this variant is rare. It is not a common variation found in the general population and is specifically associated with a clinical condition.
What should I do if I have this variant?
If you have been identified as a carrier of this variant, you should consult with a medical geneticist or a genetic counselor. They can provide a clinical assessment and discuss appropriate medical management or screening options.
Does having this variant mean I will definitely get sick?
Pathogenic variants in the NF2 gene have high penetrance, meaning they are very likely to lead to clinical symptoms over a lifetime. However, the severity and specific symptoms can vary between individuals, and professional medical evaluation is required to understand your specific risk.
Sources & further reading
Educational information only, last refreshed 10/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1060503667?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29